Filing Details
- Accession Number:
- 0001209191-11-055029
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-08 18:00:40
- Reporting Period:
- 2011-11-08
- Filing Date:
- 2011-11-08
- Accepted Time:
- 2011-11-08 18:00:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1100962 | Endo Pharmaceuticals Holdings Inc | ENDP | Pharmaceutical Preparations (2834) | 134022871 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1034273 | Michael Hyatt | 383 Madison Avenue 43Rd Floor New York NY 10179 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, Par Value, $0.01 Per Share | Acquisiton | 2011-11-08 | 5,000 | $11.00 | 5,000 | No | 4 | M | Direct | |
Common Stock, Par Value, $0.01 Per Share | Disposition | 2011-11-08 | 5,000 | $32.31 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | 2000 Stock Incentive Plan Options | Disposition | 2011-11-08 | 5,000 | $0.00 | 5,000 | $11.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2012-03-12 | No | 4 | M | Direct |
Footnotes
- This represents the average price that Mr. Hyatt's common shares were sold at on November 8, 2011.
- Mr. Hyatt's stock options that were granted under the 2000 Stock Incentive Plan on March 12, 2002 were exercisable 25% per year on each of March 12, 2003, March 12, 2004, March 12, 2005 and March 12, 2006. The 5,000 stock options that were exercised now represent all of the shares exercisable from Mr. Hyatt's original grant of 5,000 stock options.
- These securities were granted to Mr. Hyatt in consideration of his services on the Endo Pharmaceuticals Holdings Inc. Board of Directors.